Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical verapamil + nitroglycerin + lidocaine gel to prevent radial artery spasm
IRCT20200128046296N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of verapamil, nitroglycerin and lidocaine in Chronic Coronary Syndrome (CCS) and radial artery spasm, sponsored by Tehran University of Medical Sciences. Primary endpoint: Incidence of radial artery spasm. Started Apr 2020; status: completed.
02
Drugs
verapamilnitroglycerinlidocaine
03
Conditions
Chronic Coronary Syndrome (CCS)radial artery spasm
Beyond the preview
Go deeper on IRCT20200128046296N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200128046296N1.